人类的新陈代谢和分泌动力学Bronopol口服后的口服
Isabell Schönrath1, Christoph Schmidtkunz2, Katharina E Ebert3
1Currenta GmbH & Co. OHG, Institute of Biomonitoring, Chempark Gebäude Q 18, 51368, Leverkusen, Germany. isabell.schoenrath@currenta.biz.
Archives of toxicology
|May 20, 2025
概括
通过在尿液中测量其代谢物2-nitro-1,3-propanediol,可以监测布朗诺波的暴露. 这种生物标志物可以准确评估人类群体的布朗诺波尔摄入量和风险.
科学领域:
- 毒理学 毒理学 毒理学
- 药理动力学 药理动力学
- 生物监测 生物监测
背景情况:
- 布朗诺波是工业,化品和制药产品中广泛使用的防腐剂.
- 了解布朗诺波尔对人类的毒动力学对于评估暴露风险至关重要.
研究的目的:
- 为了研究布朗诺波尔在口服后对人类的毒动力学.
- 为了识别和量化一个适合bronopol暴露的生物标志物.
主要方法:
- 布朗诺波尔 (9.715毫克) 通过口服给五名健康志愿者.
- 在服用后48小时内收集尿液.
- 使用经过验证的生物监测方法对代谢物2-nitro-1,3-propanediol进行尿液分析.
主要成果:
- 在尿液中检测到了代谢物2-nitro-1,3-propanediol.
- 剂量后大约2.5小时,在尿液中达到最大度.
- 平均有29.2%的口服剂量以2-nitro-1,3-propanediol的形式分泌,其半衰期为6.3小时.
结论:
- 2-nitro-1,3-propanediol 是一个合适的生物标志物,用于评估 Bronopol 对人类的暴露.
- 尿液分泌数据可用于逆向计算bronopol摄入量,帮助暴露和风险评估.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
66
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
66
Factors Influencing Drug Absorption: Presystemic Elimination
169
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
169
Drug Elimination: Overview
933
Drug elimination involves many complex processes and does not necessarily differentiate between distribution and elimination. It is divided into two primary components: excretion and biotransformation.
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
933
Kinetics of Drug Elimination
3.3K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
3.3K
Pharmacokinetics: Overview
5.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.3K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K


